Brief Report: Self-Reported HIV-Positive Status but Subsequent HIV-Negative Test Results in Population-Based HIV Impact Assessment Survey Participants-11 Sub-Saharan African Countries, 2015-2018.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 Apr 2024
Historique:
received: 06 06 2023
accepted: 05 10 2023
medline: 27 2 2024
pubmed: 27 2 2024
entrez: 27 2 2024
Statut: ppublish

Résumé

HIV testing is a critical step to accessing antiretroviral therapy (ART) because early diagnosis can facilitate earlier initiation of ART. This study presents aggregated data of individuals who self-reported being HIV-positive but subsequently tested HIV-negative during nationally representative Population-Based HIV Impact Assessment surveys conducted in 11 countries from 2015 to 2018. Survey participants aged 15 years or older were interviewed by trained personnel using a standard questionnaire to determine HIV testing history and self-reported HIV status. Home-based HIV testing and counseling using rapid diagnostic tests with return of results were performed by survey staff according to the respective national HIV testing services algorithms on venous blood samples. Laboratory-based confirmatory HIV testing for all participants identified as HIV-positives and self-reported positives, irrespective of HIV testing results, was conducted and included Geenius HIV-1/2 and DNA polymerase chain reaction if Geenius was negative or indeterminate. Of the 16,630 participants who self-reported as HIV-positive, 16,432 (98.6%) were confirmed as HIV-positive and 198 (1.4%) were HIV-negative by subsequent laboratory-based testing. Participants who self-reported as HIV-positive but tested HIV-negative were significantly younger than 30 years, less likely to have received ART, and less likely to have received a CD4 test compared with participants who self-reported as HIV-positive with laboratory-confirmed infection. A small proportion of self-reported HIV-positive individuals could not be confirmed as positive, which could be due to initial misdiagnosis, deliberate wrong self-report, or misunderstanding of the questionnaire. As universal ART access is expanding, it is increasingly important to ensure quality of HIV testing and confirmation of HIV diagnosis before ART initiation.

Sections du résumé

BACKGROUND BACKGROUND
HIV testing is a critical step to accessing antiretroviral therapy (ART) because early diagnosis can facilitate earlier initiation of ART. This study presents aggregated data of individuals who self-reported being HIV-positive but subsequently tested HIV-negative during nationally representative Population-Based HIV Impact Assessment surveys conducted in 11 countries from 2015 to 2018.
METHOD METHODS
Survey participants aged 15 years or older were interviewed by trained personnel using a standard questionnaire to determine HIV testing history and self-reported HIV status. Home-based HIV testing and counseling using rapid diagnostic tests with return of results were performed by survey staff according to the respective national HIV testing services algorithms on venous blood samples. Laboratory-based confirmatory HIV testing for all participants identified as HIV-positives and self-reported positives, irrespective of HIV testing results, was conducted and included Geenius HIV-1/2 and DNA polymerase chain reaction if Geenius was negative or indeterminate.
RESULTS RESULTS
Of the 16,630 participants who self-reported as HIV-positive, 16,432 (98.6%) were confirmed as HIV-positive and 198 (1.4%) were HIV-negative by subsequent laboratory-based testing. Participants who self-reported as HIV-positive but tested HIV-negative were significantly younger than 30 years, less likely to have received ART, and less likely to have received a CD4 test compared with participants who self-reported as HIV-positive with laboratory-confirmed infection.
CONCLUSIONS CONCLUSIONS
A small proportion of self-reported HIV-positive individuals could not be confirmed as positive, which could be due to initial misdiagnosis, deliberate wrong self-report, or misunderstanding of the questionnaire. As universal ART access is expanding, it is increasingly important to ensure quality of HIV testing and confirmation of HIV diagnosis before ART initiation.

Identifiants

pubmed: 38412045
doi: 10.1097/QAI.0000000000003363
pii: 00126334-202404010-00002
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

313-317

Subventions

Organisme : U.S. Presidentâ€s Emergency Plan for AIDS Relief
ID : #U2GGH001271and #U2GGH001226.

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no funding or conflicts of interest to disclose.

Références

WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Recommendations for a Public Health Approach. World Health Organization; 2016. https://www.who.int/publications/i/item/9789241549684
Lasry A, Kalou MB, Young PR, et al. Cost implications of HIV retesting for verification in Africa. PLoS One. 2019;14:e0218936.
Kufa T, Lane T, Manyuchi A, et al. The accuracy of HIV rapid testing in integrated bio-behavioral surveys of men who have sex with men across 5 provinces in South Africa. Medicine (Baltimore). 2017;96:e7391.
Kufa T, Kharsany AB, Cawood C, et al. Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing. J Int AIDS Soc. 2017;20(suppl 6):21753.
Shanks L, Klarkowski D, O'Brien DP. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS One. 2013;8:e59906.
Kosack CS, Shanks L, Beelaert G, et al. HIV misdiagnosis in sub-Saharan Africa: performance of diagnostic algorithms at six testing sites. J Int AIDS Soc. 2017;20:21419.
Jahun I, Ehoche A, Bamidele M, et al. Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018). PLoS One. 2022;17:e0273748.
Xia Y, Milwid RM, Godin A, et al. Accuracy of self-reported HIV-testing history and awareness of HIV-positive status in four sub-Saharan African countries. AIDS (London, England). 2021;35:503–510.
Sachathep K, Radin E, Hladik W, et al. Population-based HIV impact assessments survey methods, response, and quality in Zimbabwe, Malawi, and Zambia. J Acquir Immune Defic Syndr. 2021;87(suppl 1):S6–S16.
Patel HK, Duong YT, Birhanu S, et al. A comprehensive approach to assuring quality of laboratory testing in HIV surveys: lessons learned from the population-based HIV impact assessment project. J Acquir Immune Defic Syndr. 2021;87(suppl 1):S17–S27.
Johnston LG, Sabin ML, Prybylski D, et al. The importance of assessing self-reported HIV status in bio-behavioural surveys. Bull World Health Organ. 2016;94:605–612.
Harbertson J, Hale BR, Tran BR, et al. Self-reported HIV-positive status but subsequent HIV-negative test result using rapid diagnostic testing algorithms among seven sub-Saharan African military populations. PLoS One. 2017;12:e0180796.
Johnson CC, Fonner V, Sands A, et al. To err is human, to correct is public health: a systematic review examining poor quality testing and misdiagnosis of HIV status. J Int AIDS Soc. 2017;20(suppl 6):21755.
Johnson CC, Dalal S, Baggaley R, et al. A public health approach to addressing and preventing misdiagnosis in the scale-up of HIV rapid testing programmes. J Int AIDS Soc. 2017;20(suppl 6):22190.
Gray RH, Makumbi F, Serwadda D, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ. 2007;335:188.
World Health Organization. Consolidated Guidelines on HIV Testing Services. World Health Organization; 2019. https://www.who.int/publications/i/item/978-92-4-155058-1
World Health Organization. WHO Encourages Countries to Adapt HIV Testing Strategies in Response to Changing Epidemic. World Health Organization; 2019. https://www.who.int/publications/i/item/WHO-CDS-HIV-19.34
Fogel JM, Piwowar-Manning E, Debevec B, et al. Brief report: impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays. J Acquir Immune Defic Syndr. 2017;75:426–430.

Auteurs

Naeemah Z Logan (NZ)

Epidemic Intelligence Service, CDC, Atlanta, GA.
Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Peter H Kilmarx (PH)

Fogarty International Center, National Institutes of Health, Bethesda, MD.

Italia Rolle (I)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Hetal K Patel (HK)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Yen T Duong (YT)

ICAP-Columbia University, New York, NY.

Kiwon Lee (K)

ICAP-Columbia University, New York, NY.

Judith D Shang (JD)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Stephane Bodika (S)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Isabelle T Koui (IT)

Ministry of Health, Abidjan, Côte d'Ivoire.

Shirish Balachandra (S)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.
Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Michelle Li (M)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Kristin Brown (K)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Harriet Nuwagaba-Biribonwoha (H)

ICAP-Columbia University, New York, NY.

Yimam Getaneh (Y)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Sileshi Lulseged (S)

ICAP-Columbia University, New York, NY.

Ashenafi Haile (A)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Christine A West (CA)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Yohannes Mengistu (Y)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Stephen D McCracken (SD)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Thokozania Kalua (T)

Ministry of Health, Lilongwe, Malawi.

Andreas Jahn (A)

Department for HIV and AIDS, Ministry of Health and Population, Lilongwe, Malawi.
I-TECH, Department of Global Health, University of Washington, Seattle, WA.

Evelyn Kim (E)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Nellie Wadonda-Kabondo (N)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Sasi Jonnalagadda (S)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Ndapewa Hamunime (N)

Namibia Ministry of Health and Social Services, Windhoek, Namibia.

Daniel B Williams (DB)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

James McOllogi Juma (J)

Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, Tanzania.
Tanzania National AIDS Control Program, Dodoma, Tanzania.

George S Mgomella (GS)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Rennatus Mdodo (R)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Wilford L Kirungi (WL)

Ministry of Health, Kampala, Republic of Uganda; and.

Veronicah Mugisha (V)

ICAP-Columbia University, New York, NY.

Clement B Ndongmo (CB)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Kennedy Chibeta Nkwemu (KC)

Fogarty International Center, National Institutes of Health, Bethesda, MD.

Owen Mugurungi (O)

Ministry of Health and Child Care, Harare, Zimbabwe.

John H Rogers (JH)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Suzue Saito (S)

ICAP-Columbia University, New York, NY.

Paul Stupp (P)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Jessica E Justman (JE)

ICAP-Columbia University, New York, NY.

Andrew C Voetsch (AC)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Bharat S Parekh (BS)

Division of Global HIV and TB, Center for Global Health, CDC, Atlanta, GA.

Classifications MeSH